<strong>An analysis on related factors influencing the plasma concentration of imatinib mesylate in the treatment of gastrointestinal stromal tumors</strong>

doi:10.3781/j.issn.1000-7431.2021.2111-0854

PDF(961 KB)

Tumor ›› 2022, Vol. 42 ›› Issue (08) : 533-541. DOI: 10.3781/j.issn.1000-7431.2021.2111-0854

An analysis on related factors influencing the plasma concentration of imatinib mesylate in the treatment of gastrointestinal stromal tumors

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 42(08): 533-541 https://doi.org/10.3781/j.issn.1000-7431.2021.2111-0854

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(961 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Accepted	Published
2021-09-23	2022-03-20	2022-08-25
Issue Date
2022-08-25

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

QR code of this article

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS